1983
DOI: 10.1097/00005344-198301000-00005
|View full text |Cite
|
Sign up to set email alerts
|

Glucose, Insulin, Potassium Protection During the Course of Hypothermic Global Ischemia and Reperfusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

1985
1985
2014
2014

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(29 citation statements)
references
References 1 publication
0
29
0
Order By: Relevance
“…It was possible to enhance the recovery of myocardial function with antioxidant drugs or enzymes able to scavenge free radicals during experimental heart ischaemia and reperfusion phase (Hess et al, 1983;Schlafer et al, 1982).…”
Section: Discussionmentioning
confidence: 99%
“…It was possible to enhance the recovery of myocardial function with antioxidant drugs or enzymes able to scavenge free radicals during experimental heart ischaemia and reperfusion phase (Hess et al, 1983;Schlafer et al, 1982).…”
Section: Discussionmentioning
confidence: 99%
“…ionic balance, membrane potential), particularly if the specific enzymes required for glucose breakdown exist in close proximity to the cell membrane (Runnman et al, 1990). In addition, exogenous glucose may further protect the in situ heart by acting as a free radical scavenger during reoxygenation (Hess et al, 1983). Although glucose uptake was not measured, it is possible that the in situ hearts used in this study had an enhanced rate of glucose uptake from the hypoxic perfusate compared to our previous studies (Arthur et al, 1992;Gamperl et al, 2001), and that this enhanced the post-hypoxic recovery of myocardial function.…”
Section: Potential Adaptations Mediating Hypoxia Tolerancementioning
confidence: 99%
“…jury in the setting of ischemic heart disease gained widespread interest. Although most experimental studies demonstrated that glucose or GIK improved cardiac function and reduced injury during myocardial ischemia (5-12) or hypoxia (13)(14)(15)(16)(17)(18), clinical studies have yielded conflicting results (4,(19)(20)(21)(22)(23)(24)(25)(26). Some of the discrepancies may be related to the severity of ischemia, since in experimental studies the benefit of GIK during low-flow moderate ischemia was lost during severe ischemia (12), probably owing to more complete inhibition of anaerobic glycolysis and poorer delivery of substrate to the ischemic area.…”
Section: Introductionmentioning
confidence: 99%
“…For example, GIK has consistently been found to lower circulating levels of free fatty acids, which are known to be deleterious in the setting of myocardial ischemia, and this action has been proposed as an alternate explanation for the beneficial effects of GIK (7,9,10). Other potentially significant factors include preservation of cardiac glycogen stores (28-31), membrane-stabilizing effect of insulin (7,27), increased osmotic pressure (5), and free radical scavenging effects of glucose (18).…”
Section: Introductionmentioning
confidence: 99%